Kidney transplantation for primary glomerulonephritis: Recurrence risk and graft outcomes with related versus unrelated donors

Transplant Rev (Orlando). 2021 Apr;35(2):100584. doi: 10.1016/j.trre.2020.100584. Epub 2020 Oct 11.

Abstract

Primary glomerulonephritis can recur after kidney transplantation and may jeopardize the survival of the renal allograft. The risks of living-related kidney transplantation remain controversial in this group of patients. Living related transplantation offers potentially better HLA matching, therefore improve the long-term graft survival. However, the concern for increased rates of recurrence of the primary glomerulonephritis in the transplanted kidney from living related donors complicates the selection of donors. With the recent dramatic rise in the use of paired kidney exchange, there is now often the option of having a living related donor donate through a paired exchange. This raises the question of whether patients with primary glomerulonephritis should receive living donor kidneys through paired kidney exchange programs to obtain the benefits of a living donor kidney transplant while also reducing the risk of recurrent glomerulonephritis. Our review of the literature suggests that although the recurrence of primary glomerulonephritis occurs more often when donation occurs from a living related donor as compared to an unrelated donor, the graft survival advantage of living related donation is generally maintained despite the recurrence. We suggest that despite the increased risk of recurrence, living related donation should not be avoided in patients with primary glomerulonephritis as the cause of their end-stage renal disease.

Keywords: Deceased donor kidney transplantation; Living unrelated kidney transplantation; Living-related kidney transplantation; Primary glomerulonephritis; Recurrence risk.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glomerulonephritis* / epidemiology
  • Graft Survival
  • Humans
  • Kidney Transplantation* / adverse effects
  • Living Donors
  • Recurrence
  • Registries
  • Unrelated Donors